Heparin Dosing During Percutaneous Coronary Intervention and Obesity

*Division of Cardiovascular Medicine, Indiana University School of Medicine/Indiana University Health Methodist, Indianapolis, IN;

†Cardiology, Franciscan Health, Lafayette, IN;

‡Department of Medicine, Cleveland Clinic Akron General, Akron, OH; and

§Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, CA.

Correspondence: Rolf P. Kreutz, MD, Department of Medicine, Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University School of Medicine/Indiana University Health, MPC 2, ME-400, 1801 N Capitol Ave, Indianapolis, IN 46202 (e-mail: [email protected]).

The authors report no conflicts of interest.

留言 (0)

沒有登入
gif